Liberty Wealth Management LLC Has $200,000 Stock Position in Phreesia, Inc. (NYSE:PHR)

Liberty Wealth Management LLC grew its holdings in Phreesia, Inc. (NYSE:PHR) by 6,030.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,260 shares of the company’s stock after acquiring an additional 12,060 shares during the quarter. Liberty Wealth Management LLC’s holdings in Phreesia were worth $200,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the stock. Geode Capital Management LLC increased its holdings in shares of Phreesia by 19.3% during the second quarter. Geode Capital Management LLC now owns 627,264 shares of the company’s stock worth $38,451,000 after purchasing an additional 101,538 shares during the period. Vanguard Group Inc. grew its position in Phreesia by 24.8% during the second quarter. Vanguard Group Inc. now owns 2,085,987 shares of the company’s stock worth $127,871,000 after buying an additional 414,895 shares in the last quarter. Vident Investment Advisory LLC bought a new position in Phreesia during the 2nd quarter worth $218,000. FMR LLC raised its holdings in Phreesia by 4.4% in the 2nd quarter. FMR LLC now owns 6,908,396 shares of the company’s stock valued at $423,484,000 after acquiring an additional 288,633 shares in the last quarter. Finally, Rhenman & Partners Asset Management AB lifted its position in shares of Phreesia by 333.3% during the 2nd quarter. Rhenman & Partners Asset Management AB now owns 260,000 shares of the company’s stock valued at $15,938,000 after acquiring an additional 200,000 shares during the period. Institutional investors and hedge funds own 93.90% of the company’s stock.

In related news, General Counsel Allison C. Hoffman sold 2,082 shares of Phreesia stock in a transaction that occurred on Wednesday, August 25th. The shares were sold at an average price of $69.05, for a total transaction of $143,762.10. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP David Linetsky sold 4,978 shares of the company’s stock in a transaction that occurred on Wednesday, September 1st. The shares were sold at an average price of $70.42, for a total transaction of $350,550.76. The disclosure for this sale can be found here. Insiders have sold 181,368 shares of company stock worth $12,804,059 over the last three months. Insiders own 5.60% of the company’s stock.

NYSE PHR opened at $62.55 on Thursday. The firm’s fifty day moving average price is $66.00 and its two-hundred day moving average price is $59.33. The stock has a market cap of $3.18 billion, a PE ratio of -58.46 and a beta of 1.21. The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.56 and a current ratio of 8.56. Phreesia, Inc. has a fifty-two week low of $30.50 and a fifty-two week high of $81.59.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Tuesday, August 31st. The company reported ($0.48) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.22) by ($0.26). Phreesia had a negative net margin of 27.94% and a negative return on equity of 13.18%. The firm had revenue of $51.01 million for the quarter, compared to analyst estimates of $47.22 million. During the same period last year, the business earned ($0.17) EPS. The company’s revenue was up 45.7% compared to the same quarter last year. As a group, sell-side analysts predict that Phreesia, Inc. will post -1.38 earnings per share for the current fiscal year.

A number of research analysts recently commented on the company. Royal Bank of Canada raised their price target on Phreesia from $51.00 to $60.00 and gave the stock a “sector perform” rating in a research report on Thursday, September 2nd. KeyCorp raised their target price on shares of Phreesia from $70.00 to $73.00 and gave the company an “overweight” rating in a report on Monday, July 12th. JPMorgan Chase & Co. upped their price target on shares of Phreesia from $64.00 to $68.00 and gave the stock an “overweight” rating in a report on Thursday, June 17th. Zacks Investment Research upgraded shares of Phreesia from a “sell” rating to a “hold” rating in a research report on Thursday, August 5th. Finally, Raymond James boosted their price objective on shares of Phreesia from $65.00 to $75.00 and gave the company an “outperform” rating in a research report on Friday, September 3rd. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $69.10.

About Phreesia

Phreesia, Inc is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products.

Further Reading: What is a capital gain?

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR).

Institutional Ownership by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.